Yayınlanmış 1 Ocak 2018 | Sürüm v1
Dergi makalesi Açık

Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer

  • 1. Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, Ankara, Turkey
  • 2. Hacettepe Univ, Canc Inst, Dept Basic Oncol, Ankara, Turkey
  • 3. Aalborg Univ, Fac Sci & Engn, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark
  • 4. Gazi Univ, Fac Med, Dept Pathol, Ankara, Turkey
  • 5. Ankara Univ, Fac Med, Dept Internal Med, Ankara, Turkey
  • 6. Hacettepe Univ, Fac Med, Dept Anat, Ankara, Turkey

Açıklama

Purpose: The aim of this study is to test folate-conjugated cyclodextrin nanoparticles (FCD-1 and FCD-2) as a vehicle for reducing toxicity and increasing the antitumor efficacy of paclitaxel especially for metastatic breast cancer.

Dosyalar

bib-3d261f30-df5a-40b2-a33a-4313b0ca5549.txt

Dosyalar (328 Bytes)

Ad Boyut Hepisini indir
md5:8f009e32f29ad90e53c9237b088d06cb
328 Bytes Ön İzleme İndir